.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently, Chennai witnessed the launch of iLive Connect, a doctor-led ecosystem focused on AI healthcare monitoring. This innovative platform uses a wireless biosensor patch and a wearable wristband to track vital parameters in real-time. Consequently, clinicians can supervise patients outside traditional hospital settings. Since India faces a high cardiovascular burden, this technology aims to reduce sudden cardiac deaths effectively. Moreover, the system facilitates early identification of potential risks before they escalate into serious illnesses.
Experienced doctors at a remote command center track physiological data 24/7. They alert families immediately if they detect any clinical abnormalities in the patient. Dr. Rahul Chandola emphasized that traditional symptom-driven care often proves inadequate for asymptomatic individuals. Therefore, continuous monitoring helps identify subclinical issues that episodic evaluations might miss. Furthermore, the platform allows for multi-day screenings to capture data under real-world conditions, providing a comprehensive profile for early risk stratification.
The technology specifically addresses the vulnerable post-discharge phase for surgical patients. Patients often face high risks during the first month after leaving the hospital. Additionally, this platform manages chronic conditions like diabetes, hypertension, and asthma. Elderly patients living independently also benefit from this constant medical support and access to doctors. Ultimately, these systems ensure continuity of care and minimize unrecognized complications during the recovery process. This approach significantly reduces the likelihood of emergency readmissions.
Q1: What specific parameters does the iLive Connect patch monitor?
The wireless biosensor patch and wristband monitor critical vital parameters including heart activity and blood pressure in real-time.
Q2: How does the system help patients with chronic conditions like diabetes?
The platform provides ongoing physiological monitoring and data-driven alerts, helping clinicians manage conditions like diabetes, hypertension, and COPD remotely.
Q3: Why is continuous monitoring better than traditional check-ups?
Continuous monitoring identifies transient or subclinical abnormalities that doctors might miss during standard, single-point diagnostic tests or episodic hospital visits.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Chennai introduces iLive Connect, a doctor-led AI platform for 24/7 remote monitoring of cardiac and chronic conditions to improve patient outcomes....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
